RBC Europe’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

RBC Europe’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	112	–	–	﹤0.01%	589
2022 Q1	$2K	Hold	112	–	–	﹤0.01%	607
2021 Q4	$3K	Hold	112	–	–	﹤0.01%	587
2021 Q3	$2.42K	Sell	112 -1,285	-92%	-$31K	﹤0.01%	1110
2021 Q2	$35.8K	Hold	1,397	–	–	﹤0.01%	680
2021 Q1	$25.5K	Sell	1,397 -1,465	-51%	-$24.3K	﹤0.01%	708
2020 Q4	$33K	Hold	2,862	–	–	﹤0.01%	603
2020 Q3	$21.8K	Hold	2,862	–	–	﹤0.01%	625
2020 Q2	$18.8K	Hold	2,862	–	–	﹤0.01%	640
2020 Q1	$14.6K	Hold	2,862	–	–	﹤0.01%	613
2019 Q4	$22K	Hold	2,862	–	–	﹤0.01%	630
2019 Q3	$15.2K	Hold	2,862	–	–	﹤0.01%	696
2019 Q2	$16K	Buy	2,862 +1,285	+81%	+$5.3K	﹤0.01%	699
2019 Q1	$6.7K	Hold	1,577	–	–	﹤0.01%	893
2018 Q4	$6.47K	Hold	1,577	–	–	﹤0.01%	880
2018 Q3	$10.8K	Hold	1,577	–	–	﹤0.01%	831
2018 Q2	$6.18K	Buy	1,577 +1,465	+1,308%	+$5.08K	﹤0.01%	935
2018 Q1	$327	Hold	112	–	–	﹤0.01%	1092
2017 Q4	$435	Hold	112	–	–	﹤0.01%	1102
2017 Q3	$352	Buy	+112	New	+$421	﹤0.01%	1102

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RBC Europe's CDMO Position: Q2 2022 in Review

RBC Europe held its Avid Bioservices, Inc. Common Stock (CDMO) position steady in Q2 2022 at 112 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

RBC Europe first reported a position in CDMO in Q3 2017 and has held it in 20 quarters since. The position peaked at $35.8K in Q2 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

RBC Europe held 112 shares of Avid Bioservices, Inc. Common Stock worth $2K as of Q2 2022.
RBC Europe left its Avid Bioservices, Inc. Common Stock share count unchanged in Q2 2022.
Avid Bioservices, Inc. Common Stock made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #589 holding.
RBC Europe first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Avid Bioservices, Inc. Common Stock position peaked at $35.8K in Q2 2021.
187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.